Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

318.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 66,065
  • Market Cap: £318.00m
  • RiskGrade: 125

Thursday broker round-up UPDATE

Date: Thursday 12 Sep 2013

LONDON (ShareCast) - African Minerals: Deutsche Bank cuts target price from 550p to 450p and retains a buy recommendation. Citi lowers target price from 380p to 320p keeping a buy recommendation.

Aggreko: Deutsche Bank reduces target price from 2100p to 1870p, while staying with its buy recommendation.

ARM Holdings: Goldman Sachs raises target price from 1400p to 1500p and retains its strong buy recommendation. Numis ups target price from 750p to 800p maintaining a reduce rating.

Ashmore Group: Morgan Stanley lowers target price from 420p to 410p, while its equal-weight rating remains unchanged.

Aveva: Goldman Sachs increases target price from 3600p to 4450p and reiterates a strong buy recommendation.

Barclays: Investec cuts target price from 345p to 330p downgrading from buy to add.

Barratt Developments: Citi moves target price from 315p to 330p and maintains a neutral rating.

Berendsen: Investec increases target price from 828p to 958p, while downgrading from buy to add.

Betfair: Jefferies raises target price from 930p to 1175p and keeps a buy recommendation.

Bodycote: Citi takes target price from 525p to 665p upgrading to neutral.

Bovis Homes Group: Panmure Gordon shifts target price from 801p to 806p and reiterates its hold recommendation.

Blinkx: Goldman Sachs increases target price from 152p to 215p and stays with its buy recommendation.

British American Tabacco: Societe Generale cuts target price from 3650p to 3550p and maintains its hold recommendation.

Fidessa: Goldman Sachs raises target price from 2050p to 2630p, while retaining a neutral rating.

Greene King: JP Morgan downgrades to neutral with a target price of 880p.

Imagination Technologies: Goldman Sachs ups target price from 310p to 390p and stays with its buy recommendation.

Kier Group: Liberum Capital increases target price from 1500p to 1800p and stays with its buy recommendation. Investec raises target price from 1500p to 1955p maintaining a buy recommendation. Numis takes target price from 1670p to 1950p, but downgrades to add.

Kingfisher: Bank of America moves target price from 400p to 450p leaving its neutral rating unchanged. Cantor Fitzgerald raises target price from 300p to 400p and retains a hold recommendation. Deutsche Bank takes target price from 360p to 400p reiterating a hold recommendation. Societe Generale ups target price from 392p to 414p leaving its hold recommendation unaltered.

Marston's: JP Morgan cuts target price from 180p to 160p and downgrades to neutral.

Melrose: Citi moves target price from 295p to 305p, while downgrading to neutral.

Micro Focus: Goldman Sachs shifts target price from 770p to 775p, while downgrading from neutral to sell.

Mitchells & Butlers: JP Morgan downgrades to underweight with a target price of 410p.

Oxford BioMedica: N+1 Singer shifts target price from 4p to 3.60p retaining its buy recommendation.

Oxford Resources: N+1 Singer ups target price from 1390p to 1425p maintaining a hold recommendation.

Pace: Goldman Sachs takes target price from 330p to 370p and retains a neutral rating.

Playtech: JP Morgan raises target price from 800p to 825p keeping its overweight rating.

Premier Foods: Investec ups target price from 120p to 160p, but downgrades from buy to hold.

Reed Elsevier: Jefferies takes target price from 700p to 884p and reiterates its buy recommendation.

Restaurant Group: JP Morgans ups target price from 620p to 665p retaining an overweight rating.

SABMiller: Nomura reduces target price from 3300p to 2800p and downgrades from neutral to reduce.

Sage Group: Goldman Sachs takes target price from 366p to 410p and reiterates a neutral rating.

Spectris: Citi increases target price from 2326p to 2650p and maintains a buy recommendation.

Spirax-Sarco-Engineering: Citi raises target price from 2905p to 3040p, while downgrading to hold.

Spirent Communications: Goldman Sachs moves target price from 165p to 175p and stays with a neutral rating.

Telecity: Goldman Sachs ups target price from 1200p to 1230p keeping a buy recommendation.

Thalassa Holdings: WH Ireland raises target price from 185p to 310p and retains a buy recommendation.

TUI Travel: JP Morgan upgrades to overweight with a target price of 410p.

Vedanta Resources: Alphavalue shifts target price from 1126.20p to 1121.60p, while upgrading from sell to reduce.

WANdisco: Panmure Gordon downgrades from buy to hold with an unchanged target price of 1149p.

Wolfson Microelectronics: Goldman Sachs moves target price from 145p to 160p, but still recommends selling.

Young & Co's Brewery: JP Morgan ups target price from 910p to 980p, while downgrading to neutral.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 318.00p
Change Today -2.00p
% Change -0.63 %
52 Week High 470.00
52 Week Low 166.80
Volume 66,065
Shares Issued 100.00m
Market Cap £318.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average
51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
11:54 500 @ 318.50p
11:41 73 @ 318.00p
11:27 628 @ 320.39p
11:27 100 @ 319.50p
11:27 614 @ 319.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page